TY - JOUR
T1 - Somatostatin Receptor Scintigraphy for Bronchial Carcinoid Follow-Up
AU - Fanti, Stefano
AU - Farsad, Mohsen
AU - Battista, Giuseppe
AU - Monetti, Francesco
AU - Montini, Gian Carlo
AU - Chiti, Arturo
AU - Savelli, Giordano
AU - Petrella, Francesco
AU - Bini, Alessandro
AU - Nanni, Cristina
AU - Romeo, Annadina
AU - Franchi, Roberto
AU - Bombardieri, Emilio
AU - Canini, Romeo
AU - Monetti, Nino
PY - 2003/7
Y1 - 2003/7
N2 - Purpose: Somatostatin receptor scintigraphy (SRS) has been used to diagnose bronchial carcinoids (BC) and is a valuable tool for accurate staging of BC. The aim of this study was to evaluate the role of SRS in restaging BC and following patients after treatment. Methods: Thirty-one patients (18 male, 13 female) with confirmed BC who were referred during the last 7 years were included. Patients were examined via chest radiograph (12 studies), chest or abdominal computed tomography (CT; 28 scans), chest magnetic resonance imaging (2 scans), and liver ultrasound (5 scans). Results: Overall, in 22 patients (71%), SRS confirmed the data obtained by other diagnostic procedures (16 negative and 6 positive findings). In 6 patients, SRS showed focal lesions not previously demonstrated. In 2 patients, SRS resolved uncertain findings of CT. In 1 patient, SRS showed fewer lesions compared with CT. In 8 of 31 patients, important diagnostic information obtained by SRS was not revealed by any other imaging procedure. Conclusion: Our results indicate that SRS is a reliable, noninvasive method that could be considered the principal follow-up procedure in patients with BC.
AB - Purpose: Somatostatin receptor scintigraphy (SRS) has been used to diagnose bronchial carcinoids (BC) and is a valuable tool for accurate staging of BC. The aim of this study was to evaluate the role of SRS in restaging BC and following patients after treatment. Methods: Thirty-one patients (18 male, 13 female) with confirmed BC who were referred during the last 7 years were included. Patients were examined via chest radiograph (12 studies), chest or abdominal computed tomography (CT; 28 scans), chest magnetic resonance imaging (2 scans), and liver ultrasound (5 scans). Results: Overall, in 22 patients (71%), SRS confirmed the data obtained by other diagnostic procedures (16 negative and 6 positive findings). In 6 patients, SRS showed focal lesions not previously demonstrated. In 2 patients, SRS resolved uncertain findings of CT. In 1 patient, SRS showed fewer lesions compared with CT. In 8 of 31 patients, important diagnostic information obtained by SRS was not revealed by any other imaging procedure. Conclusion: Our results indicate that SRS is a reliable, noninvasive method that could be considered the principal follow-up procedure in patients with BC.
KW - Bronchial Carcinoid
KW - Somatostatin Receptor Scintigraphy
UR - http://www.scopus.com/inward/record.url?scp=10744233746&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10744233746&partnerID=8YFLogxK
U2 - 10.1097/00003072-200307000-00003
DO - 10.1097/00003072-200307000-00003
M3 - Article
C2 - 12819406
AN - SCOPUS:10744233746
VL - 28
SP - 548
EP - 552
JO - Clinical Nuclear Medicine
JF - Clinical Nuclear Medicine
SN - 0363-9762
IS - 7
ER -